Redmile Group, Director: Fate Therapeutics FATE Buy · Filed 23/12/28

Trade details

Type: Insider buy
Amount: $166,023.6
Shares · price: 44,630 sh · $3.72 a share
Held after: 13,180,388 sh
Stock: Fate Therapeutics FATE
Person: Redmile GroupDirector
Trade date: 23/12/26
Filed: 23/12/28
Days to filing: 2 days

2 insiders bought this week

Insiders buying this week: 2 insiders
Holding change: +0.3%

Fate Therapeutics trades, last 26 weeks

What else happened in Fate Therapeutics around then

Filed or reported within 30 days of the trade day · 23/11/26~24/01/25

Redmile Group's recent trades

Redmile Group10% Owner
SellADC Therapeutics
Sell
ADC Therapeutics
ADCT
$8.6M
2,634,506 sh
$8.6M
Filed 04/02
Traded 04/02
Redmile Group10% Owner
SellADC Therapeutics
Sell
ADC Therapeutics
ADCT
$8.3M
2,529,491 sh
$8.3M
Filed 04/02
Traded 04/02
Redmile Group10% Owner
SellADC Therapeutics
Sell
ADC Therapeutics
ADCT
$735.9K
196,229 sh
$735.9K
Filed 04/02
Traded 03/31
Redmile Group10% Owner
SellADC Therapeutics
Sell
ADC Therapeutics
ADCT
$706.5K
188,407 sh
$706.5K
Filed 04/02
Traded 03/31
Redmile Group10% Owner
SellADC Therapeutics
Sell
ADC Therapeutics
ADCT
$643.2K
169,265 sh
$643.2K
Filed 04/02
Traded 04/01